AQW 53196/22-27 Written question to the Minister of Health
To ask the Minister of Health whether any assessment has been made of how leukaemia survival rates in Northern Ireland compare to other nations in the United Kingdom.
Asked by Connie Egan MLA on 28 September 2026
- Answered
- Written
- Tabled
- 28 September 2026
- Answer due by
- 13 October 2026
- Answered
- 13 October 202615 days after tabling
- Department
- Department of Health
- Priority question
- No
Answer
Cancer survival is commonly reported using Age Standardised Net Survival (ASNS), which estimates the probability of survival following a cancer diagnosis after adjusting for deaths from causes other than cancer.
The most recent available leukaemia data indicates that one-year ASNS for adults aged 15-99 diagnosed with leukaemia in Northern Ireland during the period 2019-2023 was 80%. One-year ASNS was 75.4% for Scotland (2018-2022), 74.2% for Wales (2018-2022) and 74.2% for England (2015-2019).
However, direct comparisons should be interpreted with caution as the data relates to different diagnosis periods and may be influenced by differences in the mix of leukaemia sub-types included within each dataset.
Cancer survival is commonly reported using Age Standardised Net Survival (ASNS), which estimates the probability of survival following a cancer diagnosis after adjusting for deaths from causes other than cancer.
The most recent available leukaemia data indicates that one-year ASNS for adults aged 15-99 diagnosed with leukaemia in Northern Ireland during the period 2019-2023 was 80%. One-year ASNS was 75.4% for Scotland (2018-2022), 74.2% for Wales (2018-2022) and 74.2% for England (2015-2019).
However, direct comparisons should be interpreted with caution as the data relates to different diagnosis periods and may be influenced by differences in the mix of leukaemia sub-types included within each dataset.